Dynamics of allograft fibrosis in pediatric liver transplantation

American Journal of Transplantation

Volumn 14, Issue 7, 2014, Pages 1648-1656

  Venturi, C ^a   Sempoux, C ^a   Quinones, J A ^b   Bourdeaux, C ^a   Hoyos, S P ^c   Sokal, E ^b   Reding, R ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Allograft survival; children; liver fibrosis; liver transplantation; long term outcome; scoring system

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; AUTOANTIBODY; BASILIXIMAB; CYCLOSPORIN; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISOLONE; TACROLIMUS;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ARTICLE; BILIARY TRACT DISEASE; CADAVER DONOR; CHILD; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FIBROGENESIS; GRAFT RECIPIENT; HISTOPATHOLOGY; HOSPITALIZED CHILD; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; LIVER ALLOGRAFT FIBROSIS; LIVER ALLOGRAFT FIBROSIS SCORE; LIVER FIBROSIS; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER ISCHEMIA; LIVER TRANSPLANTATION; LIVING DONOR; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; METAVIR SYSTEM; MORPHOMETRICS; PEDIATRIC SURGERY; PORTAL VEIN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SCORING SYSTEM; VASCULAR DISEASE; ALLOGRAFT; FIBROSIS; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; INFANT; LIVER CIRRHOSIS; LIVER FUNCTION TEST; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; TRANSPLANTATION TOLERANCE;

ADOLESCENT; ALLOGRAFTS; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; INFANT; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; PROGNOSIS; TRANSPLANTATION TOLERANCE;

EID: 84903159725     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12740     Document Type: Article

References (33)

1. Ng VL, Fecteau A, Shepherd R, et al. Outcomes of 5-year survivors of pediatric liver transplantation: Report on 461 children from a North American Multicenter Registry. Pediatrics 2008; 122: e1128-e1135.
2. Bourdeaux C, Brunati A, Janssen M, et al. Liver retransplantation in children. A 21-year single-center experience. Transpl Int 2009; 22: 416-422.
3. Scheenstra R, Peeters PM, Verkade HJ, Gouw AS., Graft fibrosis after pediatric liver transplantation: Ten years of follow-up. Hepatology 2009; 49: 880-886.
4. Evans HM, Kelly DA, McKiernan PJ, Hubscher S., Progressive histological damage in liver allografts following pediatric liver transplantation. Hepatology 2006; 43: 1109-1117.
5. Sohrabpour AA, Mohamadnejad M, Malekzadeh R., Review article: The reversibility of cirrhosis. Aliment Pharmacol Ther 2012; 36: 824-832.
6. Pares A, Caballeria J, Bruguera M, Torres M, Rodes J., Histological course of alcoholic hepatitis. Influence of abstinence, sex and extent of hepatic damage. J Hepatol 1986; 2: 33-42.
7. Lau DT, Kleiner DE, Park Y, Di Bisceglie AM, Hoofnagle JH., Resolution of chronic delta hepatitis after 12 years of interferon alfa therapy. Gastroenterology 1999; 117: 1229-1233.
8. Hammel P, Couvelard A, O'Toole D, et al. Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med 2001; 344: 418-423.
9. Dufour JF, DeLellis R, Kaplan MM., Reversibility of hepatic fibrosis in autoimmune hepatitis. Ann Intern Med 1997; 127: 981-985.
10. Venturi C, Sempoux C, Bueno J, et al. Novel histologic scoring system for long-term allograft fibrosis after liver transplantation in children. Am J Transplant 2012; 12: 2986-2996.
11. Bourdeaux C, Pire A, Janssen M, et al. Prope tolerance after pediatric liver transplantation. Pediatr Transplant 2013; 17: 59-64.
12. Calne R., " Prope" tolerance: Induction, lymphocyte depletion with minimal maintenance. Transplantation 2005; 80: 6-7.
13. Demetris A, Adams D, Bellamy C, et al. Update of the International Banff Schema for Liver Allograft Rejection: Working recommendations for the histopathologic staging and reporting of chronic rejection. An international panel. Hepatology 2000; 31: 792-799.
14. Kerkar N, Hadzic N, Davies ET, et al. De-novo autoimmune hepatitis after liver transplantation. Lancet 1998; 351: 409-413.
15. Mieli-Vergani G, Vergani D., Autoimmune liver diseases in children-What is different from adulthood ? Best Pract Res Clin Gastroenterol 2011; 25: 783-795.
16. Menghini G, Lauro G, Ghergo GF., Latest developments in liver biopsy. Quad Sclavo Diagn 1971; 7: 1213-1220.
17. Goodman ZD, Becker RL Jr, Pockros PJ, Afdhal NH., Progression of fibrosis in advanced chronic hepatitis C: Evaluation by morphometric image analysis. Hepatology 2007; 45: 886-894.
18. Abraham SC, Freese DK, Ishitani MB, Krasinskas AM, Wu TT., Significance of central perivenulitis in pediatric liver transplantation. Am J Surg Pathol 2008; 32: 1479-1488.
19. Goodman ZD., Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol 2007; 47: 598-607.
20. Garvey W., Modified elastic tissue-Masson trichrome stain. Stain Technol 1984; 59: 213-216.
21. Puchtler H, Meloan SN, Waldrop FS., Are picro-dye reactions for collagens quantitative? Chemical and histochemical considerations. Histochemistry 1988; 88: 243-256.
22. Jimenez W, Pares A, Caballeria J, et al. Measurement of fibrosis in needle liver biopsies: Evaluation of a colorimetric method. Hepatology 1985; 5: 815-818.
23. Chevallier M, Guerret S, Chossegros P, Gerard F, Grimaud JA., A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: Comparison with morphometric studies. Hepatology 1994; 20: 349-355.
24. Abdalla AF, Zalata KR, Ismail AF, Shiha G, Attiya M, Abo-Alyazeed A., Regression of fibrosis in paediatric autoimmune hepatitis: Morphometric assessment of fibrosis versus semiquantiatative methods. Fibrogenesis Tissue Repair 2009; 2: 2.
25. Martin SR, Russo P, Dubois J, Alvarez F., Centrilobular fibrosis in long-term follow-up of pediatric liver transplant recipients. Transplantation 2002; 74: 828-836.
26. Fouquet V, Alves A, Branchereau S, et al. Long-term outcome of pediatric liver transplantation for biliary atresia: A 10-year follow-up in a single center. Liver Transpl 2005; 11: 152-160.
27. Egawa H, Miyagawa-Hayashino A, Haga H, et al. Non-inflammatory centrilobular sinusoidal fibrosis in pediatric liver transplant recipients under tacrolimus withdrawal. Hepatol Res 2012; 42: 895-903.
28. Miyagawa-Hayashino A, Yoshizawa A, Uchida Y, et al. Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allografts. Liver Transpl 2012; 18: 1333-1342.
29. Ekong UD, Melin-Aldana H, Seshadri R, et al. Graft histology characteristics in long-term survivors of pediatric liver transplantation. Liver Transpl 2008; 14: 1582-1587.
30. Rosenthal P, Emond JC, Heyman MB, et al. Pathological changes in yearly protocol liver biopsy specimens from healthy pediatric liver recipients. Liver Transpl Surg 1997; 3: 559-562.
31. Reding R, Gras J, Sokal E, Otte JB, Davies HF., Steroid-free liver transplantation in children. Lancet 2003; 362: 2068-2070.
32. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994; 20: 15-20.
33. Scheuer PJ., Liver biopsy size matters in chronic hepatitis: Bigger is better. Hepatology 2003; 38: 1356-1358.